Department of Obstetrics and Gynaecology, Kenyatta National Hospital, University of Nairobi, Nairobi, Kenya.
J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):83-9. doi: 10.1097/QAI.0b013e31825bd842.
Prevention of Mother-to-Child Transmission of HIV programs require follow-up of HIV-exposed infants (HEI) for infant feeding support, prophylactic medicines, and HIV diagnosis for at least 18 months. Retention in care and receipt of HIV services are challenging in resource-limited settings. This study compared infant follow-up results when HEI services were provided within Maternal and Child Health (MCH) clinics or in specialized HIV Comprehensive Care Clinics (CCCs) in Kenya.
This observational prospective cohort study enrolled HEI at 6-8 weeks of age in 2 purposively selected hospitals with similar characteristics but different models of service delivery. In the CCC model, HEI received immunization and growth monitoring in MCH but cotrimoxazole prophylaxis and infant HIV testing in the CCC. In the MCH model, all services were provided in the MCH. Data were collected at enrollment, 14 weeks, and 6, 9, and 12 months.
From April 2008 to April 2009, 184 HEI were enrolled in the CCC cohort and 179 in the MCH cohort. Infants in MCH were 1.14, 1.42, 1.95, and 1.29 times more likely to attend 14-week, 6-, 9-, and 12-month postnatal visits, respectively, and 2.24 times (95% confidence interval: 1.57 to 3.18) more likely to attend all 4 visits. Although infants in MCH were 1.33 times (95% confidence interval: 1.10 to 1.62) more likely to have HIV antibody testing at 1 year than CCC, there were no differences for polymerase chain reaction test or cotrimoxazole initiation at 6-8 weeks.
HIV services integrated in MCH yield better follow-up of HEI than CCC.
预防母婴传播艾滋病毒项目需要对艾滋病毒暴露婴儿(HEI)进行随访,提供婴儿喂养支持、预防性药物和艾滋病毒诊断,至少 18 个月。在资源有限的环境中,保持护理和获得艾滋病毒服务是具有挑战性的。本研究比较了在肯尼亚的母婴健康(MCH)诊所或专门的艾滋病毒综合护理诊所(CCC)提供 HEI 服务时,婴儿随访结果。
本观察性前瞻性队列研究在两家具有相似特征但服务提供模式不同的医院,在 6-8 周龄时纳入 HEI。在 CCC 模式中,HEI 在 MCH 接受免疫接种和生长监测,但在 CCC 接受复方新诺明预防和婴儿 HIV 检测。在 MCH 模式中,所有服务均在 MCH 提供。在登记时、14 周时以及 6、9 和 12 个月时收集数据。
2008 年 4 月至 2009 年 4 月,184 名 HEI 被纳入 CCC 队列,179 名被纳入 MCH 队列。MCH 组的婴儿分别有 1.14、1.42、1.95 和 1.29 倍的可能性参加 14 周、6 个月、9 个月和 12 个月的产后访视,而 4 次访视全部参加的可能性则高 2.24 倍(95%置信区间:1.57 至 3.18)。尽管 MCH 组的婴儿在 1 岁时接受 HIV 抗体检测的可能性是 CCC 的 1.33 倍(95%置信区间:1.10 至 1.62),但在 6-8 周时,聚合酶链反应检测或复方新诺明的起始率没有差异。
将艾滋病毒服务纳入母婴保健服务可使 HEI 的随访效果优于 CCC。